HMGCR and Menkes disease: It is possible that patients with differing forms of MD could respond heterogeneously to the modulation of either lipoprotein metabolism (LDL-C) or intracellular cholesterol synthesis (HMGCR), with potentially unexpected compensatory responses between these two pathways, since statins induce major LDLR upregulation.